Literature DB >> 22183976

S6 kinase 2 deficiency enhances ketone body production and increases peroxisome proliferator-activated receptor alpha activity in the liver.

Kyeongjin Kim1, Suhkneung Pyo, Sung Hee Um.   

Abstract

UNLABELLED: Nutrient homeostasis is tightly regulated by the balance between energy production and utilization. During fasting, production of ketone bodies as an alternative energy source is critical to maintain nutrient homeostasis. An important component in the nutrient-sensitive signaling pathway is S6 kinase 2 (S6K2), a downstream effector of mammalian target of rapamycin. Here, we show that mice lacking S6K2 exhibit elevated levels of ketone bodies and enhanced peroxisome proliferator-activated receptor alpha (PPARα) activity upon nutrient availability. Consistent with this, knockdown of S6K2 increases the transcriptional activity of PPARα. S6K2 suppresses PPARα by associating with its corepressor, nuclear receptor corepressor 1 (NCoR1), and by inducing the recruitment of NCoR1 to the nucleus. Moreover, ob/ob mice, a genetic model of obesity, have markedly elevated S6K2 activity, and S6K2 was strongly associated with NCoR1 in the nucleus of liver cells.
CONCLUSION: Our findings suggest that S6K2 regulates hepatic energy homeostasis by repressing PPARα activity and point to its potential relevance for therapeutic strategies designed to modulate S6K2 activity as a treatment for deregulated ketone body production.
Copyright © 2012 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22183976     DOI: 10.1002/hep.25537

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  39 in total

1.  Perspective: The Potential Role of Essential Amino Acids and the Mechanistic Target of Rapamycin Complex 1 (mTORC1) Pathway in the Pathogenesis of Child Stunting.

Authors:  Richard D Semba; Indi Trehan; Marta Gonzalez-Freire; Klaus Kraemer; Ruin Moaddel; M Isabel Ordiz; Luigi Ferrucci; Mark J Manary
Journal:  Adv Nutr       Date:  2016-09-15       Impact factor: 8.701

2.  Phosphorylation of the nuclear receptor corepressor 1 by protein kinase B switches its corepressor targets in the liver in mice.

Authors:  Young Suk Jo; Dongryeol Ryu; Adriano Maida; Xu Wang; Ronald M Evans; Kristina Schoonjans; Johan Auwerx
Journal:  Hepatology       Date:  2015-07-22       Impact factor: 17.425

Review 3.  The multifaceted role of mTORC1 in the control of lipid metabolism.

Authors:  Stéphane J H Ricoult; Brendan D Manning
Journal:  EMBO Rep       Date:  2012-02-12       Impact factor: 8.807

Review 4.  Emerging roles of the corepressors NCoR1 and SMRT in homeostasis.

Authors:  Adrienne Mottis; Laurent Mouchiroud; Johan Auwerx
Journal:  Genes Dev       Date:  2013-04-15       Impact factor: 11.361

Review 5.  Transcriptional coregulators: fine-tuning metabolism.

Authors:  Laurent Mouchiroud; Lillian J Eichner; Reuben J Shaw; Johan Auwerx
Journal:  Cell Metab       Date:  2014-05-01       Impact factor: 27.287

6.  Involvement of ATF3 in the negative regulation of iNOS expression and NO production in activated macrophages.

Authors:  Da Hye Jung; Kyung-Ho Kim; Hye Eun Byeon; Hye Jin Park; Bongkyun Park; Dong-Kwon Rhee; Sung Hee Um; Suhkneung Pyo
Journal:  Immunol Res       Date:  2015-05       Impact factor: 2.829

7.  An Insulin-Responsive Sensor in the SIRT1 Disordered Region Binds DBC1 and PACS-2 to Control Enzyme Activity.

Authors:  Troy C Krzysiak; Laurel Thomas; You-Jin Choi; Sylvain Auclair; Yiqi Qian; Shan Luan; Stephanie M Krasnow; Laura L Thomas; Leonardus M I Koharudin; Panayiotis V Benos; Daniel L Marks; Angela M Gronenborn; Gary Thomas
Journal:  Mol Cell       Date:  2018-11-08       Impact factor: 17.970

8.  Decreased lipid metabolism but increased FA biosynthesis are coupled with changes in liver microRNAs in obese subjects with NAFLD.

Authors:  J Latorre; J M Moreno-Navarrete; J M Mercader; M Sabater; Ò Rovira; J Gironès; W Ricart; J M Fernández-Real; F J Ortega
Journal:  Int J Obes (Lond)       Date:  2017-01-25       Impact factor: 5.095

9.  Pharmacological inhibition of S6K1 increases glucose metabolism and Akt signalling in vitro and in diet-induced obese mice.

Authors:  Michael Shum; Kerstin Bellmann; Philippe St-Pierre; André Marette
Journal:  Diabetologia       Date:  2016-01-05       Impact factor: 10.122

Review 10.  Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies.

Authors:  Giovanni Musso; Maurizio Cassader; Roberto Gambino
Journal:  Nat Rev Drug Discov       Date:  2016-01-22       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.